跳至主要内容
临床试验/NCT04709900
NCT04709900招募中不适用

DYnamic CT Stress Myocardial perfusioN, CT Fractional Flow Reserve and Coronary CT Angiography for Optimized treatMent Strategy In Patients With sTable Chest Pain syndromEs

Rigshospitalet, Denmark2 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2021年12月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
2,000
试验地点
2
主要终点
Major Adverse Cardiovascular Events

研究概览

简要总结

The purpose of the DYNAMITE trial (Dynamic CT stress myocardial perfusion, CT fractional flow reserve (FFR-CT) and coronary CT angiography for optimized treatment strategy in patients with chest pain syndromes) is to determine the ability of combined anatomical and functional cardiac CT imaging to improve morbidity and mortality in patients with suspected or known ischemic heart disease.

详细描述

Trial design

The DYNAMITE trial is an investigator-initiated, randomised controlled, open-labelled trial conducted in the Capital Region of Copenhagen, Denmark

The following hypothesis will be tested:

  • First primary hypothesis: A treatment strategy guided by combined dynamic CT myocardial stress perfusion, FFR-CT and CT coronary angiography improves clinical outcome compared with a conventional management strategy in patients with chronic chest pain syndromes
  • Second primary hypothesis: A treatment strategy guided by combined dynamic CT stress myocardial perfusion, FFR-CT and CT coronary angiography results in improved symptom relief compared with a conventional management strategy in patients with chronic chest pain syndromes

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • Chest pain in patients with clinically suspected or confirmed ischemic heart disease
  • Clinical indication for non-acute coronary evaluation
  • Status of coronary revascularization
  • With previous coronary revascularization - all patients
  • Without previous coronary revascularization
  • Age≥65 years - all patients with chest pain
  • Age>50 - <65 years - typical angina pectoris and at least one cardiovascular risk factor and/or previous myocardial infarction
  • Typical angina requiring all 3 criteria present: a) constrictive discomfort in the front of the chest or in the neck, jaw, shoulder or arm, b) precipitated by physical exertion c) relieved by rest or nitrates within 5 min.
  • Cardiovascular risk factors: hypertension, diabetes, hypercholesterolemia, current smoking, family history of ischemic heart disease, previous stroke, peripheral artery disease

排除标准

  • Persistent chest pain and signs of ongoing acute myocardial ischemia requiring acute coronary intervention
  • Hospitalization and discharge with the confirmed diagnosis acute coronary syndrome (STEMI or NSTEMI) within the last 6 months
  • Severe valvular heart disease as primary diagnosis and/or in potential need of percutaneous or surgical valve treatment
  • Known severe heart failure (LVEF less than 35%)
  • Language, cultural or mental factors preventing the patient from understanding the informed consent form
  • Known atrial fibrillation
  • Known renal impairment (estimated Glomerular Filtration Rate below <30 ml/min)
  • Known x-ray contrast allergy
  • Known intolerance to adenosine infusion

结局指标

主要结局

Major Adverse Cardiovascular Events

时间窗: 3 years

cardiovascular death, acute myocardial infarction, stroke or hospitalization for heart failure

次要结局

  • Number of coronary revascularization(3 years)
  • Number of invasive coronary test not leading to coronary revascularization(12 months)
  • Quality of life by EQ-5D-5L instrument(3 months and 12 months)
  • Hospitalization due to unstable angina pectoris, bleeding, pacemaker and/or implantable/cardioverter defibrillator implantation, surgical or percutaneous heart valve treatment(3 years)
  • Major procedural complications occuring during procedures (invasive, non-invasive or coronary revascularization)(12 months)
  • Minor procedural complication specific to type of procedure (invasive, non-invasive or during coronary revascularization)(12 months)
  • Seattle Angina Questionaire(3 months and 12 months)
  • Acute myocardial infarction stratified by subtype(12 months)
  • All-cause mortality(10 years)
  • Number and type of diagnostic tests performed(12 months)
  • Individual components of the primary endpoint(3 years)
  • Cumulative iodinated contrast volume(12 months)
  • Patients diagnosed with non-cardiac disease as likely explanation for symptoms(12 months)
  • Cumulative radiation dose(12 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Klaus Fuglsang Kofoed

Clinical associated Research Professor

Rigshospitalet, Denmark

研究点 (2)

Loading locations...

相似试验

CT Stress Myocardial Perfusion, Fractional Flow... | 临床试验